Literature DB >> 8353693

Psychological treatment of generalised anxiety disorder. A review of the clinical significance of results in outcome studies since 1980.

R C Durham1, T Allan.   

Abstract

Comparative outcome studies of generalised anxiety disorder suggest that psychological therapy is a potentially valuable alternative to anxiolytic medication. However, on average psychological therapy results in modest improvements in symptoms, with about 50% of patients achieving normal functioning. Limited follow-up data indicate that these changes are maintained over six months. Cognitive therapy appears to be most effective, although comparisons with other therapies are limited and non-specific factors are clearly important. There is also evidence of considerable variability in outcome between studies, with the best results obtained with patients who are free of anxiolytic medication and recruited directly from primary care or other non-psychiatric settings. The effects on outcome of patient characteristics known to be associated with more severe illness and complexity of clinical presentation have yet to be explored. A balanced appraisal of the value of psychological therapy with this common condition requires a fuller description of sample characteristics and more systematic investigation of the clinical significance of treatment effects over the long term.

Entities:  

Mesh:

Year:  1993        PMID: 8353693     DOI: 10.1192/bjp.163.1.19

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  3 in total

Review 1.  Treatment of anxiety.

Authors:  M Lader
Journal:  BMJ       Date:  1994-07-30

2.  Psychotherapy--a luxury the NHS cannot afford? Unevaluated or inefficient approaches are hard to justify.

Authors:  I Marks
Journal:  BMJ       Date:  1994-10-22

3.  Acceptability, effectiveness and cost-effectiveness of blended cognitive-behavioural therapy (bCBT) versus face-to-face CBT (ftfCBT) for anxiety disorders in specialised mental health care: A 15-week randomised controlled trial with 1-year follow-up.

Authors:  Geke Romijn; Neeltje Batelaan; Jeroen Koning; Anton van Balkom; Aart de Leeuw; Friederike Benning; Leona Hakkaart van Roijen; Heleen Riper
Journal:  PLoS One       Date:  2021-11-12       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.